The Use of Daily, Intranasal Oxytocin for the Treatment of Childhood-Onset Schizophrenia (COS), a Randomized Double-Blind Trial
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Oxytocin (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 07 Jul 2017 Biomarkers information updated
- 16 Nov 2012 New trial record